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Summary We investigated the presence of colony-stimulating factor (CSF) in supernatants obtained from
TS/A, a new metastatic murine cell line, and from its high-and low-metastatic clonal derivatives (E and F
clones, respectively). TS/A cells produced a CSF in vitro that induced proliferation and differentiation of
murine monocytic and granulocytic progenitors in agar cultures. In TS/A-bearing mice remarkable
splenomegaly, blood granulocytosis and thymus depletion were observed along with a stimulatory activity in
serum and a strong proliferative activity both in spleen and in bone marrow populations. Conditioned media
from E clones showed an in vitro colony-stimulating activity greater than those of F clones. Mice injected
subcutaneously with cells of all clones studied showed granulocytosis, splenomegaly and thymus depletion,
although to varying degrees. However, no direct correlation between granulocytosis-splenomegaly and the
number of spontaneous lung metastases was observed.
Haemopoietic alterations, with marked granulo-
cytosis and myeloid spleen hyperplasia, with no
evidence of infections, have been frequently
observed in animals during the growth of trans-
plantable tumours (Burlington et al., 1977; Reincke
et al., 1978; Lee et al., 1980; Balducci & Hardy,
1983). Granulocytosis has also been reported
sometimes in patients with various cancers (Okabe
et al., 1978, 1982; Suda et al., 1980) and in nude
mice transplanted with human tumours (Asano et
al., 1977; Okabe et al., 1978; Sato et al., 1979; Suda
et al., 1980; Mizoguchi et al., 1982; Okabe et al.,
1982). Moreover, colony-stimulating activity has
been detected in conditioned media from cell lines
derived from murine (Burlington et al., 1977;
Balducci & Hardy, 1983; Milas et al., 1984) and
human (Okabe et al., 1982) transplantable tumours.
Quantitative and qualitative haemopoietic
alterations could play an important role in the
metastatic process and the study of the production
of colony-stimulating factor(s) (CSF) by metasta-
sizing tumours could help to clarify if and when
such an influence exists. Therefore, we studied the
production of colony-stimulating activity by TS/A
line, a new murine spontaneous mammary car-
cinoma cell line that metastasizes spontaneously
to the lungs (Nanni et al., 1983) and by its high-
and low-metastatic clonal derivatives (Lollini et al.,
1984). Data are presented here on the haemopoietic
alterations observed during in vivo growth of TS/A
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and clones, on the detection of in vitro produced
CSF and on the comparison between this activity
and metastatic potential.
Materials and methods
Mice
Eight-12 week-old female BALB/cAnNCRIBR mice
(hereafter referred to as BALB/c), purchased from
Charles River, Calco, Italy, or bred in our facilities
were used throughout the study.
Cell lines and clonal derivatives
The parental TS/A cell line was derived from a
spontaneous mammary adenocarcinoma which
arose in a retired breeder BALB/c female (Nanni et
al., 1983). Clonal derivatives with different meta-
static potential, which have been previously selected
and characterized (Lollini et al., 1984), were also
used in the present study: E1, E2 and E3 clones are
highlymetastatic and Fl, F2 and F5, arepoorlymeta-
static. In the experiments here reported, TS/A cells
were between the 20th and the 35th in vitro passage
and clones were between the 30th and the 45th in
vitro passage after cloning.
A cell line derived from the B16 melanoma of
C57BL/6 origin (kindly provided by Dr A.
Mantovani, Istituto Mario Negri, Milan, Italy) was
used as a control in some experiments.
All cell lines and clones were cultured in
Dulbecco's MEM supplemented with 2mM
glutamine, 100Uml-1 penicillin, 100 ugml-1
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streptomycin (referred to as DMEM) and with 10%
heat-inactivated foetal calf serum (FCS) (GIBCO,
Paisley, Scotland) in a 5% CO2 humidified
atmosphere at 370C and were routinely subcultured
twice weekly by trypsin-EDTA treatment.
Assaysfor CSF activity
Assays for detection of CSF production were made
on conditioned media obtained as follows: 1-2 x 106
cells were seeded in 75cm2 flasks and cultured in
DMEM+10% FCS. Supernatants were collected 3
days later, centrifuged at 3000rpm for 20min and
filtered through 0.45pm Millex filters (Millipore).
At the same time, monolayers were processed to
determine cell number/flask.
The ability of conditioned media to induce bone
marrow proliferation was tested as reported
elsewhere (Pessina et al., 1981): 105 bone marrow
cells from normal BALB/c mice were cultured in
35mm Petri dishes with 1 ml semisolid medium
(McCoy's 5A medium, 20% FCS [GIBCO], 0.3%
Difco agar [DIFCO Laboratories, Detroit,
Michigan, USA]) supplemented with conditioned
medium at 0.31-40% final concentration. After a
7-day culture, plates were scored microscopically
and colonies of .50 cells were counted. Colony
morphology was evaluated after staining of the
whole culture dish with May Grumwald-Giemsa
solution as reported by Konwalinka et al. (1982).
[3H]-TdR uptake assay for CSF activity was
performed according to Prystowsky et al. (1984)
with slight modifications: 5 x 104/well BALB/c
normal bone marrow cells were seeded in Microtest
II plates (Nunc, Denmark) in DMEM+15% FCS
in the presence of conditioned medium at 2.5-40%
final concentration. After 4-day culture, cells were
pulsed for 4h with 1 uCi [3H]-methylthymidine
([3H]-TdR) (6.7Cimmol-1 specific activity; NEN,
(Dreieich, Germany) and then processed by a cell
harvester (Skatron, Norway). Radioactivity was
counted in an Intertechnique SL 3000 scintillation
spectrometer (Plaisir, France), provided with 226Ra
external standard.
In vivo studies
Mice were injected s.c. with 105 or 106 viable cells.
During tumour growth the following parameters
were examined: tumour volume (calculated as 4/3i.
[(a+b)/4]3, where a=maximal tumour diameter
and b=tumour diameter perpendicular to a), or
tumour weight at sacrifice; peripheral leukocytes
(no. mm 3) and percentage of peripheral lympho-
cytes, spleen weight, spleen and thymus cell yield.
Spleen cells from TS/A-bearing mice were studied
by cytochemical (PAS-, ANAE- and peroxidase
stains) and immunofluorescence techniques: surface
immunoglobulins (SIg) were visualized with anti-
mouse IgG FITC-conjugated antiserum from Miles;
Thy 1 antigen was detected by anti-Thy 1.2 mono-
clonal antiserum from NEN.
Proliferative activity of spleen and bone marrow
cells from tumour-bearing mice was tested in a
[3H]-TdR uptake assay: 4 x 105 spleen cells or
5 x 104 bone marrow cells (collected from femurs)
were plated in each well of Microtest II plates
(Nunc, Denmark), incubated for 96h, with a final
4h pulse with 1 4uCi [3H]-TdR, and then processed
as above.
Lung metastases were enumerated as previously
described (Nanni et al., 1983) with the aid of a
dissecting microscope.
Results
Haemopoietic alterations in TS/A-bearing mice
Progressive granulocytosis, splenomegaly, and
thymus depletion were observed in BALB/c mice
s.c. injected with the TS/A cell line (Table I).
Splenomegaly was already detectable 1 week after
cell injection: both spleen weight and cell yield
reached values which were more than 5-fold greater
than control levels by the 30th day after
inoculation. At this time, spleen comprised - 10%
T cells (Thy 1-positive cells), -20% B lymphocytes
(SIg positive), -20% mature monocytes (PAS- and
ANAE-positive, peroxidase-negative) and 50%
hypogranular metamyelocytes and polymorpho-
nuclear cells (PAS- and peroxidase- partially
positive, ANAE-negative). Leukocytosis reached
values of >200,000mm 3 and was mainly due to
enlargement of the granulocytic population. The
yield of bone marrow cells in TS/A-bearing mice
seemed to be unaffected (data not shown).
A stimulating activity on the proliferation of
murine bone marrow cells was detected, by means
of the [3H]-TdR uptake assay, in serum from 30-
day TS/A-bearing mice (Table II). The stimulating
activity was proportional to the number of s.c.
injected TS/A cells and significantly greater than
the activity ofcontrol serum.
Such a stimulating activity in the serum of TS/A-
bearing mice could result in alterations in
proliferative activity of spleen and bone marrow.
Therefore, we evaluated both the spontaneous [3H]-
TdR uptake in cells from these organs at different
times after TS/A s.c. injection and their
susceptibility to the addition of TS/A conditioned
medium. Data from 30-day TS/A-bearing mice are
shown in Table III. Both spleen and bone marrow
cells from tumour-bearing animals showed a higher
proliferative activity than cells from controls: such
a difference was already evident by I week afterCSF IN THE METASTATIC TS/A CELL LINE 217
Table I In vivo characterization ofTS/A-bearing mice
Days Tumour Spleen Leukocytes Lymphocytes Thymus
after weight weight x 103 X103 % of cellyield
injectiona (mg) (mg) mm-3 mm-3 lymphocytes ( x 106)
0 - 93+6 8.7+1.4 6.7+1.1 77+3 94+19
(n= 10) (n= 10) (n= 10) (n= 10) (n=4)
7 330 192 8.7 5.4 62 54
337 133 8.4 4.4 52 44
14 490 162 7.2 3.1 43 24
602 151 5.7 2.6 45 24
21 1803 289 19.5 3.7 19 ND
1735 324 21.7 3.3 15 ND
28 2631 534 38.9 4.3 11 4
2190 591 50.4 4.0 8 9
35 ND 764 134.0 8.0 6 ND
ND 491 225.5 15.8 7 ND
a106 TS/A cells were injected s.c. in 10 female BALB/c mice; each week two animals
were killed.
ND=not determined.
Table II Stimulation of [3H]-TdR uptake in normal bone
marrow cells by serum ofTS/A-bearing BALB/c micea
[3HJ-TdR uptakeb in thepresence
ofBALBIc serum
% serum
Control
uptakeb BALB/c treatment 2.5 5 10
277 None 1,278 1,344 2,305
+34 +120 +119 +142
105 TS/A cells 1,789 3,308 4,817
+139 +221 +167
106 TS/A cells 3,158 9,729 16,280
+315 +426 +1316
'30 days after TS/A cells injection.
bMean d.p.m. + s.e. from six replicates.
Table III [3H]-TdR uptake in spleen and in bone marrow cells obtained from normal and
TS/A-bearing8 BALB/c mice and cultured in the absence and in the presence of TS/A
conditioned medium
[3H]-TdR uptakeb
Cells Source Control +10% TS/A conditioned medium
Spleen Normal BALB/c 2,440+207 5,584+724
TS/A-bearing BALB/ca 28,956+ 1989 100,791 +6,549
Bone marrow Normal BALB/c 163+13 215,736+10,511
TS/A-bearing BALB/ca 1,544+ 177 274,801 + 12,278
'30 days after 106 TS/A cells injection.
bMean d.p.m. + s.e. from six replicates.218 G. NICOLETTI et al.
TS/A injection (data not shown). Moreover, when
cells were cultured in the presence of 10% TS/A
conditioned medium, spleen cells from TS/A-
bearing mice were further stimulated to proliferate
reaching values of [3H]-TdR uptake much higher
than those of control cells; bone marrow cells from
normal and tumour-bearing animals also showed
high and similar levels of[3H]-TdR uptake.
CSF in TS/A conditioned medium
To investigate whether the TS/A cell line could
directly interfere with haemopoiesis by production
of CSF(s), and whether it retains this production in
vitro, supernatants from TS/A cultures were
collected and tested for their ability to induce bone
marrow proliferation in agar cultures and in
microwell cultures. TS/A conditioned medium was
able to induce proliferation of normal murine bone
marrow cells in agar cultures, in which granulocyte-
macrophage colonies were observed (Figure la). A
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strong stimulating activity on murine bone marrow
cells was also detected by means of the [3H]-TdR
uptake assay performed in the presence of TS/A
conditioned medium: data from a representative
experiment are given in Figure Ib, where up to a
2,000-fold stimulation was obtained. Conditioned
medium from an unrelated cell line (B16
melanoma) showed no activity (data not shown).
Colony-stimulating activity in TS/A clonal
derivatives
We had recently derived high- and low-metastatic
clones (E and F clones, respectively) from the
parental TS/A cell line (Lollini et al., 1984). To
investigate whether all clonal derivatives produced
CSF and whether a direct relationship occurred
between such an activity and metastatic potential,
we compared three high-metastatic E clones with
three low-metastatic F clones.
Conditioned media from all 6 clones were able to
E
a
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Figure 1 Effect of TS/A conditioned medium on in vitro cultures of normal BALB/c bone marrow cells: (a)
induction of granulocyte-macrophage colonies in agar cultures (difference between replicates was always
<5%). Control=0 colonies. (b) stimulation of [3H]-TdR uptake (standard error did not exceed 10% of the
mean of 6 replicate values). Control= 163dpm.
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induce proliferation of murine monocytic and
granulocytic progenitors in agar cultures yielding
pure granulocyte, macrophage and mixed colonies
(Figure 2a), but supernatants from E clones
induced higher numbers of colonies than super-
natants from F clones. A higher in vitro activity by
conditioned media from E clones was also shown
by means of [3H]-TdR uptake in murine bone
marrow cells (Figure 2b). In both assays super-
natants from F clones also showed an activity
lower than those observed with E clones when the
plateau was reached (at concentrations of
conditioned medium ranging from 10 to 40% and
from 20 to 40% for the colony and the [3H]-TdR
uptake assays, respectively). The differences among
clones in cell size and in doubling time cannot
account for this phenomenon.
In all clones examined, tumour-bearing mice
showed progressive leukocytosis, mainly due to
enlargement of the granulocytic population, even
though values of leukocytes among different clones
were scattered (Table IV). On the whole,
comparison between E and F clones did not show
different group patterns. It should be underlined
n
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that a very low leukocytosis was observed in F5
tumour-bearing mice. Animals were then sacrificed
when individual mean tumour diameters exceeded
2.2cm, and leukocytes no. mm3, spleen weight
and number of lung metastases were evaluated for
each group (Table V). Leukocytosis and spleno-
megaly did not appear to be directly related to the
number of lung metastases: the F2 clone induced
the highest leukocytosis and splenomegaly but a
very low number of metastases. It is emphasized
that, even when comparison among clones was
made in conditions of similar tumour dimensions,
the leukocytosis induced by the F5 clone (near
24,000mm-3) remained much lower than that
observed with other clones.
Discussion
Qualitative and quantitative haemopoietic
alterations could play an important role in the
metastatic process. Enhancement of lung
colonization has been reported to occur in
association with increasing granulocytosis (Milas et
b
2.5 5 10 20
Figure 2 Effect of conditioned media from TS/A clones on in vitro cultures of normal BALB/c bone marrow
cells: (a) induction of granulocyte-macrophage colonies in agur cultures (difference between replicates was
always <5%). Control=0 colonies; (b) stimulation of [3H]-TdR uptake (standard error did not exceed 10%
of the mean of 6 replicate values). Control=293dpm. (O) El; (-) E2; (A) E3; (0) F1; (A) F2; (a) F5.220 G. NICOLETTI et al.
Table IV Haematological parameters of BALB/c mice during in vivo growth of
TS/A clones
Days after s.c. injection of105 cells
15 35
Tumour Leukocytes % of Tumour Leukocytes % of
Clonea volumeb X 103 mm -3 lymphocytes volumeb X 103mm -3 lymphocytes
El 1.0+0.2 10.4+1.2 35+3 8.2+0.6 97.8+23.0 6+1
E2 0.3+0.1 7.5+1.1 48+8 4.7+0.6 47.1+12.2 18+6
E3 0.5+0.1 11.3+1.6 37+5 5.8+0.7 101.9+21.6 7+1
Fl 0.2+0.1 6.2+0.8 64+5 2.4+0.5 73.4+39.9 16+6
F2 0.7+0.2 10.7+1.0 34+3 6.5+0.8 350.5+25.7 3+1
F5 0.1+0.0 5.7+0.9 79+4 2.1+0.3 11.6+ 1.5 33+3
a5 animals/group.
bSee Materials and methods.
Table V Leukocytosis, splenomegaly and spontaneous lung metastases in
BALB/c mice injected s.c. with TS/A clones and sacrificed when tumour
diameter exceeded 2.2cm
Tumour Time at Leukocytes Spleen Median no. of
Clonea volumeb sacrifice' X 103mm -3 weight (mg) lung metastases
El 7.4+0.7 37+1 100.3+14.7 522+40 >200
E2 7.6+0.5 43+2 115.5+24.1 555+57 101
E3 6.1+0.4 39+1 119.0+18.7 550+33 >200
F1 6.1+0.2 47+3 161.1+31.6 450+50 36
F2 6.6+0.7 37+1 375.4+22.6 1,119+61 16
F5 7.7+0.6 57+4 24.0± 3.9 357+ 17 14
aS animals/group.
bSee Materials and methods.
'Days after cell injection.
al., 1984) and a correlation between splenomegaly
and metastases has been suggested (Sato et al.,
1981).
We studied in vitro colony-stimulating activity
and in vivo haemopoietic alterations in the new
murine TS/A cell line, that has been derived from a
spontaneous mammary carcinoma and is able to
metastasize spontaneously to the lung (Nanni et al.,
1983). Moreover, we examined two sets of clones
selected from TS/A line, which are all able to
metastasize spontaneously but strongly differ in
metastatic potential (E clones induce higher
numbers of lung metastases than F clones) (Lollini
et al., 1984).
TS/A conditioned medium exerted a colony-
stimulating activity on granulocyte-macrophage
progenitors. Moreover, when the TS/A line was
injected s.c., progressive spleen enlargement and
thymic atrophy as well as a dramatic increase in
peripheral granulocytic population were observed.
Even though the TS/A line is able to metastasize,
spleen was free from metastases and not able tQ
induce tumours, when injected into syngeneic
animals (data not shown). Serum from TS/A-
bearing mice was also found to stimulate
proliferation of normal murine bone marrow cells.
Therefore, a colony-stimulating activity was
detected both in TS/A conditioned medium and in
serum from TS/A bearing animals. However, the
possibility that the alterations we observed in vivo
could be due also to an interaction between tumour
and host cells cannot be ruled out.
In vitro production of CSF and in vivo occurrence
of splenomegaly and granulocytosis have been
shown for all the TS/A clonal derivatives examined.
We observed a discrepancy between in vitro and in
vivo assays. In vitro both agar colony and [3H]-TdR
uptake assays seem to indicate that supernatantsCSF IN THE METASTATIC TS/A CELL LINE 221
from E clones have a CSF activity higher than
those of F clones. On the contrary, such a pattern
was not revealed by in vivo studies: mice injected
with F2 cells displayed the strongest leukocytosis
and splenomegaly whereas those injected with F5
cells were the least altered and all the other groups
ranged in between.
We could not find any correlation between in
vivo haematological parameters and other charac-
teristics of TS/A clonal derivatives, such as in vitro
doubling time, cell dimensions or in vivo tumour
volume. We are currently examining three different
hypotheses: either our cell lines produce a second
factor which cannot be detected in vitro, or in vitro
growth pattern of F clones does not allow a high
CSF production, or some interaction with host
environment occurs that alters CSF in vivo
production.
When the possibility of a correlation between
CSF production and metastases is considered, in
vitro production of CSF clearly correlates with the
relative metastatic capacity of E and F clones, but
again in vivo haematologic parameters do not.
Moreover, it should be borne in mind that E and F
clones probably differ in the early steps of the
metastatic process, since they do not give rise to
significantly different numbers of lung colonies,
when injected intravenously.
In conclusion, we believe that the relationship
between CSF production and the metastatic process
should be further explored, in particular in relation
to late events (such as survival in the blood stream
and attachment and growth in target organs) and
possible reciprocal interactions between CSF-
producing tumour cells and host cells elicited by
CSF itself.
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